Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Oxford Biotherapeutics
Biotech
Chutes & Ladders—Gilead’s commercial head to retire
Meyers retires as Gilead's commercial head, Kewalramani was promoted to Vertex's CMO, Recipharm CFO Stenqvist jumped ship to Sobi.
Angus Liu
Mar 2, 2018 9:00am
OBT raids Celgene for CMO as I-O trial plan takes shape
Mar 1, 2018 7:49am
Boehringer takes up option on Oxford BioTherapeutics oncology target
Apr 21, 2016 1:38am